Nattokinase NSK-SD
Nattokinase has been shown to degrade fibrin clots both in clot lysis assays comparable to plasmin and by affecting plasminogen activator inhibitor 1 (PAI-1), which is the primary inhibitor of tissue-type plasminogen activator (t-PA).
Human clinical studies have demonstrated the ability of nattokinase to decrease euglobin (clot) lysis time (ELT) up to 8 hours after oral intake of a dose of natto estimated at 6,000 fibrin degradation units (FU). In addition, euglobulin fibrinolytic activity (EFA; lysis area on a fibrin plate) was increased significantly up to 12 hours following administration.

Suggested Use / Directions:
Take one capsule once daily. Consult health care practitioner for use beyond 4 weeks.

Serving Size:
1 capsule

Medicinal Ingredients:

Nattokinase ... 100 mg

Non-Medicinal Ingredients:
Cellulose, maltodextrin, hydroxypropyl methylcellulase, magnesium stearate.


Storage
Keep at room temperature in a dry, dark place. Keep out of reach of children. Safety sealed for your protection.

Cautions and Warnings
Do not use if you are pregnant or breastfeeding, if you are taking health products that affect blood coagulation, or if you have a bleeding disorder. Consult a health practitioner if you have a cardiovascular, kidney or liver disorder, or if you are taking any medications. Stop using this product 7 days before any scheduled surgery, or immediately if you have unscheduled surgery or if you suffer any injury resulting in bruising or bleeding. This product is derived from soy. Do not use if you have soy allergy.